© 2017 Stanningly Pharma

Tel: +44 (0) 115 912 4253  Email: info@stanningleypharma.co.uk

BioCity, Pennyfoot Street, Nottingham NG1 1GF

  • White Facebook Icon
  • White Twitter Icon
  • White Google+ Icon

Renacet®

 

Renacet® Film-coated calcium acetate tablets
Indication hyperphosphataemia associated with chronic renal insufficiency in patients undergoing dialysis. 1

Price

12% cost saving
Savings are based on NHS list prices for other calcium acetate preparations on mg equivalence. 2

Renacet 475    200 tablets    £9.71

Renacet 950   200 tablets  £18.45

NICE

1st line phosphate binder
“For adults, offer calcium acetate as the first line phosphate binder to control serum phosphate in addition to dietary management.” 3

 

Choice
Two strengths 475/950mg tablets
Tablet size /strength allows tailoring to suit patient needs.

​Pack Size only available as 200 tablet packs 

Legal Category P

 

References

  1. Renacare NephroMed GmbH, Summary of Product Characteristics, Renacet 475mg and 950mg, film-coated tablets, December 2014.

  2. MIMS Online accessed November 2017

  3. NICE Guideline CG157 March 2013 Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease

 

Ordering

Product Renacet® 475mg Calcium Acetate Prescription Medicine

1 unit pack size contains 200 coated tablets

NHS list price (ex VAT) £9.71

EAN 4027052102120

PIP 3594199

Wholesalers Alliance Healthcare, AAH Pharmaceuticals Ltd, Sangers

 

Product Renacet® 950mg Calcium Acetate Prescription Medicine

1 unit pack size contains 200 coated tablets

NHS list price (ex VAT) £18.45

EAN 4027052102229

PIP 3594207

Wholesalers Alliance Healthcare, AAH Pharmaceuticals Ltd, Sangers

 For further information regarding products or purchasing please contact Stanningley Pharma: Info@stanningleypharma.co.uk or tel 0115 9124253 

Download the

Summary Patient Information

Leaflet

If you require multiple printed versions of these leaflets please contact us

You are now leaving the Stanningley Pharma website. The company cannot guarantee the accuracy of the information on sites it does not own or control.

BNF

MIMS